Put Buying Surges as Stocks Slide Into September

Defensive options positioning dominated the week of August 31. Across five high-severity pulses, traders piled into protective puts on names nursing sharp price declines. The put/call ratio (PCR) — which measures put volume relative to call volume — spiked well above seasonal norms on multiple names, with several readings hitting 52-week extremes.

---

Notable Positioning Shifts

ZGN — PCR hits 52-week high ahead of earnings

The most extreme reading this week. Ermenegildo Zegna's PCR hit 12.94 on September 3 — the highest level in 52 weeks and 4.4 standard deviations above its 20-day mean. For every call bought, nearly 13 puts changed hands. The spike arrived directly ahead of the company's earnings release, suggesting options traders positioned aggressively for downside. A z-score of 4.4 is statistically severe; readings above 3.0 are rare in normal markets.

APH — Fear extreme after 49% monthly collapse

Amphenol's PCR reached 3.94, also a 52-week high, on September 4. The stock had fallen 49% over the prior month. A PCR above 1.0 already signals more puts than calls; 3.94 indicates heavily skewed protection demand. At this level, options traders are paying up for downside hedges rather than positioning for recovery.

CXM — 4.4 standard-deviation spike post-drop

Sprinklr's PCR jumped to 0.67 on September 3, against a 20-day mean of just 0.20. That is a 4.4 standard-deviation move — matching ZGN for the largest z-score of the week. The trigger was a single-session drop of 8.6%, pushing the stock to $6.95. Options traders responded immediately with protective put buying.

RUSH.A — Highest PCR in a year amid 38% slide

Rush Enterprises' PCR spiked to 0.24, its highest in 52 weeks, on September 4. That reading sits 4.3 standard deviations above the 20-day mean. Context matters here: the stock had shed 38% over the prior month. Absolute PCR levels look modest, but the z-score tells the real story — hedging demand relative to recent norms is at an extreme.

CPB — Contrarian put-buying on a 7% single-day drop

Campbell's PCR rose to 0.927 on September 4, the highest in nearly a year and 4.2 standard deviations above its 20-day mean of 0.685. Unlike the others, this pulse was flagged with a note of options bullishness — the put buying spiked on a 7% down session, suggesting some traders used the dip to position for a bounce rather than press shorts further.

---

Sector Themes

Broad defensive rotation

Activity this week was not confined to one sector. The five high-severity pulses crossed consumer staples (CPB), industrials (APH, RUSH.A), luxury goods (ZGN), and software (CXM). That breadth points to market-wide caution rather than sector-specific stress.

Earnings-driven hedging

ZGN's pre-earnings PCR spike is a well-documented options pattern. Traders buy puts before results to cap downside exposure. A 52-week-high PCR at 12.94 implies the options market priced in meaningful earnings risk — the put-to-call imbalance was among the most lopsided seen all year across any name in the dataset.

Distressed-stock options demand

Three of the five names — APH, RUSH.A, and CXM — were already deep in drawdown before the options spikes. A 49% monthly decline in APH and a 38% slide in RUSH.A suggest put buying arrived after, not before, severe price damage. In distressed-stock situations, elevated PCR often reflects short-sellers hedging existing positions rather than new directional bets.

Broader pulse universe

Beyond the five highlighted names, the week's broader pulse dataset logged activity across more than 300 tickers, including large-cap names such as AAPL, MSFT, AVGO, LLY, and NVAX. Pulse types spanned options, short interest, cost-to-borrow, and utilization signals — indicating options stress was part of a wider risk-off shift, not an isolated phenomenon.